Table 1 Perioperative criteria and pathological findings
47 patients | |
|---|---|
Age (years) | 57.65 ± 10.42 (35–78) |
Gender | |
Male | 35 (74.5%) |
Female | 12 (25.5%) |
BMI (kg/m2) | 28.19 ± 3.79 (19.1–34.77) |
Preoperative creatinine (mg/dL) | 1.27 ± 0.32 (0.6–2) |
Preoperative hemoglobin (g/dL) | 11.88 ± 1.36 (10–16) |
Postoperative creatinine (mg/dL) | 1.3 ± 0.33 (0.5–2.1) |
Postoperative hemoglobin (g/dL) | 10.11 ± 1.15 (8.9–13) |
ASA score | 3 (1–3) |
CCI score | 5 (3–9) |
Operative time (min) | 316.91 ± 35.13 (240–380) |
Cystectomy time (min) | 146.06 ± 26.92 (105–200) |
Diversion time (min) | 172.87 ± 28.22 (110–230) |
Incision for extracorporeal urinary diversion | |
Pfannenstiel | 33 (70.2%) |
Midline | 14 (29.8%) |
Extracorporeal urinary diversion type | |
Orthotopic neobladder | 35 (74.5%) |
Ileal conduit | 12 (25.5%) |
Estimated blood loss (mL) | 458.9 ± 359.2 (150–1350) |
Pain [numerical rating scale (NRS-11)] | |
Day 1 | 3 (1–6) |
Day 5 | 1 (0–2) |
ICU stay (days) | 1 (0–3) |
Time to bowel activity (days) | 2 (1–6) |
Hospital stay (day) | 10 (5–25) |
cTNM staging | |
cT2 | 27 (57.4%) |
cT3b | 20 (42.6%) |
cN0 | 0 |
cM0 | 0 |
Pathological stage | |
pT2b | 13 (27.7%) |
pT3b | 34 (72.3%) |
pN0 | 34 (72.3%) |
pN1 | 10 (21.3%) |
pN2 | 3 (6.4%) |
Reoperation | 3 (6.38%) |
Conversion to open surgery | 2/49 (4%) |